A Study of RO5190591 (Danoprevir) in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy Volunteer

In brief

This non-randomized, open-label study will evaluate the interaction of RO5190591(danoprevir)/ritonavir with and without ketoconazole and the safety and tolerability in healthy volunteers. Participants will be administered repeated daily doses of ketoconazole alone, RO5190591/ritonavir, and RO5190591/ritonavir plus ketoconazole. The anticipated time on study treatment is 25 days.

Key facts

Study ID
NCT01164488
Run by
Hoffmann-La Roche
People needed
18
Starts
2010-07-01
Expected to finish
2010-08-01
Last updated by the study team
2016-08-29

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.